Helix BioPharma Corp.
About Helix BioPharma
Helix BioPharma Corp. is a biopharmaceutical company specializing in the field of cancer therapy. The company primarily develops innovative drugs for the prevention and treatment of cancer using proprietary technologies. The company's drug developments include the topical interferon alpha-2b for the treatment of changes caused by the human papilloma virus and the novel drug candidate L-DOS47 for the treatment of lung adenocarcinoma. Helix shares are listed on the Toronto Stock Exchange under the ticker symbol "HBP".
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
Advertisement
